Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
Sponsor: AbbVie
Summary
The cumulative effect of aging and environmental exposures (ie, ultraviolet, infrared, and visible light radiation and pollution) leads to wrinkles, discoloration, laxity, and roughness of sun exposed skin. The rapid restoration of soft tissue augmentation is commonly achieved by the use of dermal fillers. HArmonyCa Lidocaine injectable gel is a dermal filler intended for facial soft tissue augmentation. The purpose of this study is to assess adverse events and effectiveness of HArmonyCa Lidocaine injectable gel compared to Restylane® Perlane® Lidocaine (Perlane) in adults seeking restoration and/or correction of moderate to severe mid-face volume deficit. HArmonyCa Lidocaine Injectable Gel is an investigational device being developed for soft tissue augmentation in the mid face. Participants are placed in 1 of 2 groups, called treatment arms. There is a 1 in 3 chance that participants will be assigned to the receive active comparator, Perlane. Around 252 adult participants seeking restoration and/or creation of mid-face volume will be enrolled in the study at approximately 9 sites in China. Participants will receive HArmonyCa Lidocaine injectable gel or Perlane at Day 1 with an option touch-up treatment on Day 31. Participants will be followed for up to 12 Months after last treatment. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.
Official title: A Multicenter, Evaluator Blinded, Randomized Study to Evaluate the Safety and Effectiveness of HArmonyCa Lidocaine Compared to Restylane® Perlane® Lidocaine for Restoration and/or Creation of Mid-face Volume
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
252
Start Date
2025-05-26
Completion Date
2026-10
Last Updated
2025-08-14
Healthy Volunteers
No
Conditions
Interventions
HArmonyCa Lidocaine Injectable Gel
Subdermal or Deep Dermal or Supraperiosteal Injection
Restylane® Perlane® Lidocaine
Subcutaneous to Supraperiosteal Implantation Injection
Locations (9)
Beijing Hospital /ID# 272476
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital (West) - Xidan Campus /ID# 272480
Beijing, Beijing Municipality, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 272631
Wuhan, Hubei, China
Nanjing Drum Tower Hospital /ID# 272468
Nanjing, Jiangsu, China
Zhongda Hospital Southeast University /ID# 272471
Nanjing, Jiangsu, China
Wuxi People'S Hospital /ID# 275928
Wuxi, Jiangsu, China
Huashan Hospital Of Fudan University /ID# 272632
Shanghai, Shanghai Municipality, China
Shanghai Tongji Hospital /ID# 272509
Shanghai, Shanghai Municipality, China
The First People's Hospital of Hangzhou /ID# 272475
Hangzhou, Zhejiang, China